781
Views
0
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

Tripterygium regelii decreases the biosynthesis of triacylglycerol and cholesterol in HepG2 cells

, , , , , , , , , & ORCID Icon show all
Pages 2285-2291 | Received 23 May 2017, Accepted 21 Sep 2017, Published online: 01 Nov 2017

References

  • Lee S, Lee MS, Kim CT, et al. Ginsenoside Rg3 reduces lipid accumulation with AMP-Activated Protein Kinase (AMPK) activation in HepG2 cells. Int J Mol Sci. 2012;13:5729–5739.10.3390/ijms13055729
  • Ma W, Ding H, Gong X, et al. Methyl protodioscin increases ABCA1 expression and cholesterol efflux while inhibiting gene expressions for synthesis of cholesterol and triglycerides by suppressing SREBP transcription and microRNA 33a/b levels. Atherosclerosis. 2015;239:566–570.10.1016/j.atherosclerosis.2015.02.034
  • Kostner GM. Pharmacology of HMG CoA reductase inhibitors (statins). Wien Med Wochenschr. 1999;149:120–124.
  • Würtz P, Wang Q, Soininen P, et al. Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase. J Am Coll Cardiol. 2016;67:1200–1210.10.1016/j.jacc.2015.12.060
  • Ali S, Khan SA, Iram S. Hypocholesterolemia secondary to atrovastatin therapy. J Ayub Med Coll Abbottabad. 2010;22:225–227.
  • Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98:2088–2093.10.1161/01.CIR.98.19.2088
  • Ornato JP. Should you worry about the side effects of statins? Statin dose, health, and other drugs affect side-effect risk. Health News. 2003;9:1–2.
  • Brinker AM, Ma J, Lipsky PE, et al. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry. 2007;68:732–766.10.1016/j.phytochem.2006.11.029
  • Hori H, Pang GM, Harimaya K, et al. Isolation and structure of regelin and regelinol, new antitumor ursene-type triterpenoids from Tripterygium regelii. Chem Pharm Bull (Tokyo). 1987;35:2125–2128.10.1248/cpb.35.2125
  • Lee GI, Ha JY, Min KR, et al. Inhibitory effects of oriental herbal medicines on IL-8 induction in lipopolysaccharide-activated rat macrophages. Planta Med. 1995;61:26–30.10.1055/s-2006-957992
  • Chen D, Ma Y, Wang X, et al. Triptolide-containing formulation in patients with autosomal dominant polycystic kidney disease and proteinuria: an uncontrolled trial. Am J Kidney Dis. 2014;63:1070–1072.10.1053/j.ajkd.2014.01.418
  • Guo J, Huang X, Wang H, et al. Celastrol induces autophagy by targeting AR/miR-101 in prostate cancer cells. PLOS One. 2015;10:e0140745.10.1371/journal.pone.0140745
  • Wang C, Shi C, Yang X, et al. Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism. Eur J Pharmacol. 2014;744:52–58.
  • Zhang R, Zhu Y, Dong X, et al. Celastrol attenuates cadmium-induced neuronal apoptosis via inhibiting Ca2+ -CaMKII-dependent Akt/mTOR pathway. J Cell Physiol. 2016;232:2145–2157.
  • Liu J, Lee J, Salazar Hernandez MA, et al. Treatment of obesity with celastrol. Cell. 2015;161:999–1011.10.1016/j.cell.2015.05.011
  • Lin LZ, Harnly JM. Phenolic compounds and chromatographic profiles of pear skins (Pyrus spp.). J Agric Food Chem. 2008;56:9094–9101.10.1021/jf8013487
  • Ferreres F, Gil-Izquierdo A, Vinholes J, et al. Bauhinia forficata Link authenticity using flavonoids profile: relation with their biological properties. Food Chem. 2012;134:894–904.10.1016/j.foodchem.2012.02.201
  • Lange BM, Fischedick JT, Lange MF, et al. Integrative approaches for the identification and localization of specialized metabolites in tripterygium roots. Plant Physiol. 2017;173:456–469.10.1104/pp.15.01593
  • Baskaran G, Salvamani S, Ahmad SA, et al. HMG-CoA reductase inhibitory activity and phytocomponent investigation of Basella alba leaf extract as a treatment for hypercholesterolemia. Drug Des. Develop Ther. 2015;9:509–517.10.2147/DDDT
  • Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124:35–46.10.1016/j.cell.2005.12.022
  • Hirano Y, Yoshida M, Shimizu M, et al. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway. J Biol Chem. 2001;276:36431–36437.10.1074/jbc.M105200200
  • Giandomenico V, Simonsson M, Gronroos E, et al. Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol Cell Biol. 2003;23:2587–2599.10.1128/MCB.23.7.2587-2599.2003
  • Sundqvist A, Bengoechea-Alonso MT, Ye X, et al. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 2005;1:379–391.10.1016/j.cmet.2005.04.010
  • Ponugoti B, Kim DH, Xiao Z, et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem. 2010;285:33959–33970.10.1074/jbc.M110.122978
  • Li Y, Xu S, Mihaylova MM, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13:376–388.10.1016/j.cmet.2011.03.009
  • Knebel B, Lehr S, Hartwig S, et al. Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2. Arch Physiol Biochem. 2014;120:216–227.10.3109/13813455.2014.973418
  • Kamada C, da Silva EL, Ohnishi-Kameyama M, et al. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic Res. 2005;39:185–194.10.1080/10715760400019638

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.